Sana banks on $100M sav­ings as it shifts man­u­fac­tur­ing plans to Wash­ing­ton state

The ex­ecs at Sana are drop­ping plans to build their new cell and gene ther­a­py man­u­fac­tur­ing fa­cil­i­ty in Cal­i­for­nia, in­stead turn­ing close to their home base in the Seat­tle hub for a site as they shave $100 mil­lion off the cost of the project.

Sana — which has seen its share price crater in the biotech bear mar­ket — inked a lease agree­ment to de­vel­op an 80,000 square-foot man­u­fac­tur­ing fa­cil­i­ty in the Seat­tle sub­urb of Both­ell, WA. While the biotech isn’t say­ing how much the new fa­cil­i­ty in Both­ell will cost, the com­pa­ny says it ex­pects this move will pro­vide $100 mil­lion in sav­ings over the next three years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER